Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.61 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.50 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5465357 | 0.86 | HPGD (0.64) | SLC29A1HPGDFGFR1FGFR4HDAC6 | |
| SCHEMBL5458583 | 0.85 | HDAC6 (0.49) | YTHDC1SLC29A1HPGDADORA2AFGFR1 | |
| SCHEMBL5458838 | 0.84 | YTHDC1 (0.76) | YTHDC1ADORA2AADORA1TP53RXFP1 | |
| SCHEMBL3394076 | 0.82 | HSP90AB1 (0.68) | YTHDC1ADORA2AADORA1HDAC6 | |
| SCHEMBL11827194 | 0.81 | HDAC6 (0.54) | YTHDC1SLC29A1HPGDFGFR1FGFR4 | |
| SCHEMBL30984022 | 0.81 | ADORA2A (0.70) | HPGDADORA2AFGFR1FGFR4HDAC6 | |
| SCHEMBL2980291 | 0.81 | ADORA2A (0.70) | HPGDADORA2AFGFR1FGFR4HDAC6 | |
| SCHEMBL30910333 | 0.81 | LPO (0.51) | YTHDC1SLC29A1FGFR1FGFR4TP53 | |
| SCHEMBL29246271 | 0.81 | LPO (0.51) | YTHDC1SLC29A1FGFR1FGFR4TP53 | |
| SCHEMBL5462823 | 0.81 | HDAC6 (0.53) | YTHDC1SLC29A1HPGDFGFR1FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070203159-A1 | Purine compounds | UNIVERSITETET I OLSO (NO) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203159-A1 | Purine compounds | PNP, UMPS, TYMP | YTHDC1 632/4885SLC29A1 17/4885HPGD 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.